Knowledge Translation in OncologyThe Bumpy Ride From Bench to Bedside

被引:7
|
作者
Morgan, Sarah [1 ,2 ]
Hanna, Jessica [1 ,2 ]
Yousef, George M. [1 ,2 ]
机构
[1] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[2] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON, Canada
关键词
Knowledge translation; Precision medicine; Molecular pathology; Personalized medicine; PRIMARY-CARE; GENOMIC MEDICINE; DECISION-SUPPORT; GENETIC SERVICES; RISK-ASSESSMENT; CANCER; INTEGRATION; PHYSICIANS;
D O I
10.1093/ajcp/aqz099
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objectives: Knowledge translation (KT) is the dynamic process of mobilizing best-practice evidence to guide health care decisions. Methods: Using a PubMed search, challenges were identified and milestones defined. Results: Substantial challenges exist in integrating discoveries into patient care, including technical limitations related to genomic testing like turnaround time, standardization, reproducibility, and results interpretation. Other challenges include lack of proper training in genetic counseling for health care providers, clarity of scientific evidence, and ethical, legal and social considerations. In addition, most health care systems lack accessibility to genetic testing services. Moving forward, KT should be addressed at three main frontiers. The first is patients centered for proper understanding and decision making; the second is directed toward health care professionals, including clinical decision support and clarity of roles; and the third addresses resources of health care systems. Conclusions: Implementing KT requires developing strategies to enhance awareness and promote behavioral changes congruent with research evidence, designing a systematic approach by health care providers and stakeholders to achieve patient-centered care.
引用
收藏
页码:5 / 13
页数:9
相关论文
共 50 条
  • [1] Knowledge Translation in Glomerulonephritis: Successes in Translational Research From the Bench to Bedside
    Yau, Kevin
    Wang, Carol
    Al Batran, Rami
    Macphee, Anne
    Beaucage, Mary
    Farragher, Janine F.
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2023, 10
  • [2] The Journey of in vivo Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road
    Goyvaerts, Cleo
    Breckpot, Karine
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [3] Molecular Pathology of Pancreatic Cancer: From Bench-to-Bedside Translation
    Corbo, Vincenzo
    Tortora, Giampaolo
    Scarpa, Aldo
    CURRENT DRUG TARGETS, 2012, 13 (06) : 744 - 752
  • [4] miRNAs: The Road from Bench to Bedside
    Iacomino, Giuseppe
    GENES, 2023, 14 (02)
  • [5] Chronic pain assessment from bench to bedside: lessons along the translation continuum
    Jensen, Bryan
    TRANSLATIONAL BEHAVIORAL MEDICINE, 2016, 6 (04) : 596 - 604
  • [6] Resveratrol in Cancer Patients: From Bench to Bedside
    Berretta, Massimiliano
    Bignucolo, Alessia
    Di Francia, Raffaele
    Comello, Francesco
    Facchini, Gaetano
    Ceccarelli, Manuela
    Iaffaioli, Rosario Vincenzo
    Quagliariello, Vincenzo
    Maurea, Nicola
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)
  • [7] MDMX: from bench to bedside
    Marine, Jean-Christophe W.
    Dyer, Michael A.
    Jochemsen, Aart G.
    JOURNAL OF CELL SCIENCE, 2007, 120 (03) : 371 - 378
  • [8] PRALATREXATE - FROM BENCH TO BEDSIDE
    Zain, J. M.
    Marchi, E.
    DRUGS OF TODAY, 2010, 46 (02) : 91 - 99
  • [9] SUMO: FROM BENCH TO BEDSIDE
    Chang, Hui-Ming
    Yeh, Edward T. H.
    PHYSIOLOGICAL REVIEWS, 2020, 100 (04) : 1599 - 1619
  • [10] Chemoprevention with isothiocyanates - From bench to bedside
    Gruendemann, Carsten
    Huber, Roman
    CANCER LETTERS, 2018, 414 : 26 - 33